Source: BioPortfolio

Teva Pharmaceuticals: Teva launches generic version of EpiPen autoinjector in US

Tevas generic version of the EpiPen Jr epinephrine injection USP AutoInjector 0.15 mg and an additional supply of Tevas generic version of the EpiPen epinephrine injection USP autoInjector The post Teva launches generic version of EpiPen autoinjector in US...

Read full article »
Teva Pharmaceuticals's Competitors | Teva Pharmaceuticals's News | Teva Pharmaceuticals's Financials
Stay up-to-date with the latest news on Teva Generics
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Allan Oberman's photo - President & CEO of Teva Generics

President & CEO

Allan Oberman

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Teva Generics